What Is XOMA Royalty Corporation (XOMA) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, XOMA Royalty Corporation's intrinsic value is estimated at $15.89, suggesting the stock is overvalued at its current price of $40.17. With 12 out of 13 models flagging downside (-60.4% average return), the market may be pricing in unsustainable growth. The most optimistic model, PWERM, places fair value at $42.99 (+7.0%), while Dynamic NAV — the most conservative — estimates $1.51 (-96.2%). This +103.3% gap reflects genuine analytical uncertainty about XOMA Royalty Corporation's intrinsic worth.
What Do the Models Say About XOMA?
13 of 13 models are currently active for XOMA. Of these, 1 model suggests upside while 12 models suggest overvaluation. The Bayesian DCF estimates XOMA's intrinsic value at $7.77, implying -80.6% downside from the current price. See which stocks rank higher →
How Does XOMA Rank in Pharmaceutical Preparations?
Among 431 Pharmaceutical Preparations stocks, XOMA ranks #103 by Quality of Company score. CirclFi's QOC score of 6.3/10 evaluates 32 fundamental signals. A score of 6.3 indicates above-average quality.
See all Most Undervalued Pharmaceutical Preparations Stocks →
As a pharmaceutical industry, XOMA Royalty Corporation operates in a sector where pipeline depth and stage distribution is a critical driver of valuation. Investors evaluating XOMA should weigh these sector-specific dynamics alongside our model-derived fair values.
Is XOMA a Value Trap?
CirclFi's Value Trap algorithm assigns XOMA a score of 32/100 (LOW). This indicates low risk. The financial profile does not exhibit typical value trap warning signs. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
13 of 13 models are active for XOMA Royalty Corporation. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi 32-factor quality framework, XOMA Royalty Corporation's fundamental quality profile registers 6.3/10. This respectable score captures the company's profitability depth, growth consistency, balance sheet resilience, and shareholder return track record.
The gap between the most bullish and bearish model spans +103.3% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every XOMA valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across XOMA's 13 active models, average confidence is 32%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad